Coronavirus: Protein treatment trial 'a breakthrough'

Coronavirus: Protein treatment trial 'a breakthrough' The preliminary results of a clinical trial suggest a new treatment for Covid-19 dramatically reduces the number of patients needing intensive care, according to the UK company that developed it.
The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection. BBC News

See also:

• Coronavirus: Boris Johnson 'does not want second national lockdown' BBC News
• Coronavirus: Councils in England get new powers for local shutdowns BBC News
• Coronavirus: Cuts 'took away' councils' crisis capacity BBC News
• Coronavirus: Are mutations making it more infectious? BBC News
• SAGE told Boris Johnson 'pre-Covid normality' impossible The Daily Mail
• Coronavirus outbreak confirmed at NHS Test and Trace Centre in Scotland The Daily Telegraph
• Coronavirus: senior doctors warn second wave could 'devastate' NHS The Guardian
• Test and trace failures risk exponential case growth in England, official warns The Guardian
• How prepared is Boris Johnson for a winter resurgence of coronavirus? The Guardian
• Senior Tory accuses Johnson of blaming NHS for government's Covid-19 failings The Guardian
• We must not let the government seize back control from doctors | Andrew Lansley The Guardian
• Daily updates on English Covid-19 deaths paused amid accuracy concerns The Guardian
• Coronavirus: The inside story of how government failed to develop a contact-tracing app Sky News